Financial reports
Current reports
8-K
CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates
8 Aug 24
8-K
Regulation FD Disclosure
24 May 24
8-K
CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates
9 May 24
8-K
Other Events
3 May 24
8-K
Departure of Directors or Certain Officers
16 Feb 24
8-K
Amendments to Articles of Incorporation or Bylaws
30 Jan 24
Registration and prospectus
S-8
Registration of securities for employees
26 Jan 24
424B4
Prospectus supplement with pricing info
25 Jan 24
S-1MEF
Registration of additional securities for an S-1
24 Jan 24
S-1/A
IPO registration (amended)
23 Jan 24
8-A12B
Registration of securities on exchange
22 Jan 24
S-1/A
IPO registration (amended)
18 Jan 24
S-1
IPO registration
2 Jan 24
DRS/A
Draft registration statement (amended)
4 Dec 23
DRSLTR
Correspondence regarding draft registration statement
4 Dec 23
DRS
Draft registration statement
27 Oct 23
Proxies
No filings
Other
SEC STAFF
SEC staff action: Order
26 Jan 24
EFFECT
Notice of effectiveness
25 Jan 24
CERT
Certification of approval for exchange listing
24 Jan 24
CORRESP
Correspondence with SEC
22 Jan 24
CORRESP
Correspondence with SEC
22 Jan 24
CORRESP
Correspondence with SEC
5 Jan 24
CORRESP
Correspondence with SEC
2 Jan 24
UPLOAD
Letter from SEC
18 Dec 23
SEC STAFF
SEC staff action: Order
27 Nov 23
UPLOAD
Letter from SEC
27 Nov 23